Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and B12 Supplementation for Chronic Hepatitis C
NCT02120274Phase 4Terminated
- Sponsor
- Federal University of São Paulo
- Start
- Mar 2014
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vitamin d and vitamin b12 in hepatitis C (HCV) (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Sustained Virologic Response 12. Started Mar 2014; status: terminated.
02
Drugs
vitamin dvitamin b12
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02120274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120274.